Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Johns Hopkins Scientists Found a Drug That Makes People Briefly Stop Feeling Like a Self
1+ day, 9+ hour ago (31+ words) They call it ego dissolution. Brain scans show something real happening when the boundary between “you” …...
Ketamine May Bring Fast Relief in Hard-to-Treat Bipolar Depression
1+ day, 16+ hour ago (312+ words) ...
Ketamine Offers Hope Against Treatment-Resistant Bipolar Depression, New Study Finds
3+ day, 5+ hour ago (600+ words) A new clinical trial found that multiple low-dose intravenous ketamine infusions significantly reduced depressive symptoms in some patients with bipolar I or bipolar II disorder. The findings, published in JAMA Psychiatry and reported by Medical Xpress and Medscape, are particularly…...
Why Psychiatric Informed Consent Needs a Stronger Legal Standard, Not Just a Clinical One
2+ day, 20+ hour ago (484+ words) Informed consent as a legal standard should assure that patient autonomy never rests on professional opinion alone. For people struggling with mental illness, psychiatric care can often be life-changing. Many treatments can have a profound positive effect on not only…...
Flow's FL-100 Wins FDA Approval for At-Home Depression Treatment
2+ day, 23+ hour ago (207+ words) Flow Neuroscience’s wireless tDCS headset cleared the FDA’s toughest approval standard, showing 57.5% remission in a 10-week trial A gentle electrical current, a smartphone app, and a clinician monitoring your data remotely. Flow Neuroscience markets FL-100 as “the first and only…...
Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
3+ day, 4+ hour ago (205+ words) Emerge Phase 3 study podium poster to be featured in “Latest Discoveries & Emerging Trends in MDD” session New epidemiological research on risks associated with anxiety and depression plus five posters across clinical program NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium…...
SPTX: Glyph platform enables novel oral therapies for depression and anxiety, advancing toward pivotal trials
3+ day, 22+ hour ago (82+ words) TradingView SPTX: Glyph platform enables novel oral therapies for depression and anxiety, advancing toward pivotal trials The company presented its neuroscience-focused pipeline, highlighting the Glyph platform's ability to overcome oral bioavailability and liver toxicity issues. Lead programs GlyphAllo and GlyphAgo…...
Flow Neuroscience Launches FDA-Approved At-Home tDCS Treatment for Major Depressive Disorder
4+ day, 22+ hour ago (285+ words) FDA-Approved FL-100 At-Home tDCS Depression Treatment in the US To bring brain stimulation directly into patients’ living rooms, Swedish medical technology company Flow Neuroscience has officially launched FL-100 across the United States, introducing the first FDA-approved at-home transcranial direct current…...
‘Tsunami’ of Behavioral Health Challenges Amid OIG’s Anti-Psychotics Work Plan Seen Impacting QMs and Reimbursement in Nursing Homes
4+ day, 18+ hour ago (1207+ words) luisda75 / Pixabay | CC0 Nursing homes have only reached the tip of the iceberg when it comes to mental health challenges in the sector, with such challenges affecting quality metrics (QMs) and reimbursement amid renewed monitoring of anti-psychotics use in facilities. Lisa Chubb,…...
What To Do When Cancel Culture Invades Your Home
5+ day, 5+ hour ago (305+ words) ‘No contact’ is Marxist cancel culture applied to homes and families. So it should be no surprise there’s now a trend of children abandoning non-abusive family members. The “no contact” movement is another logical outcome of the sexual revolution and…...